Boston-based medical technology company Elucid, which offers AI-enabled imaging analysis software for cardiovascular disease, announced that it has scored $80 million in Series C funding, bringing its total raise to $121 million.
Elevage Medical Technologies led the funding, with additional contributions from other investors.
The company will use the funds to expand the commercialization of its...
